Read More

This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors

SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma Pharmaceuticals shares fell 3.8% to close at $5.36 on Friday.

GM

Read More

Nasdaq, S&P 500 Futures Point To Weak Start For Fresh Week As Traders Eye Russia-Ukraine War Escalation, Earnings Season — Tesla, PayPal Stocks In Focus

The major U.S. index futures are pointing to a modestly lower open on Monday, as traders digest the potential escalation of the Russia-Ukraine War and look ahead to the unfolding earnings season.

AMD